Square Pharmaceuticals PLC declared a 120% cash dividend for its shareholders for the year ended 30 June 2025 at its 59th annual general meeting (AGM) held virtually on Monday.
The company's Chairman Samuel S Chowdhury presided over the AGM, says a press statement.
Ratna Patra, Vice Chairman; Tapan Chowdhury, Managing Director, Anjan Chowdhury, Director, Kazi Iqbal Harun, Director, Muhammadul Haque, Independent Director, Md. Kabir Reza, Head of A&F, Md. Zahangir Alam, Chief Financial Officer, and Khandaker Habibuzzaman, Company Secretary, attended the meeting.
The company has reported a consolidated net turnover of Tk 76.29 billion, gross profit of Tk 36.52 billion, and net profit (after tax) of Tk 20.78 billion for the year ending 30 June 2025.
The company's consolidated net turnover, gross profit, and net profit saw year-on-year growths of 8.83%, 10.43%, and 13.37% respectively.
The company contributed Tk 15.08 billion to the national exchequer.
At the AGM, the Board of Directors appreciated the performance of the officers, staff and workers whose untiring efforts helped optimise the profit of the Company.
The Directors also expressed their gratitude and acknowledged with keen interest the cooperation and unflinching support received from various agencies, including the Bangladesh Securities and Exchange Commission, stock exchanges, National Board of Revenue, and other agencies of the public and private sectors.
Many shareholders took part in the discussion on the company's performance and future expansion.
Chairman Samuel S Chowdhury expressed his deep appreciation to shareholders for their trust and support of the company's performance.